NasdaqGS:QDELMedical Equipment
A Look At QuidelOrtho (QDEL) Valuation After New Lifotronic Supply Agreement
QuidelOrtho (QDEL) has drawn fresh investor attention after announcing a long-term supply agreement with Lifotronic Technology, giving the diagnostics company access to additional immunoassay analyzers and more than 70 assays across select markets outside the United States.
See our latest analysis for QuidelOrtho.
That supply agreement arrives at a time when QuidelOrtho’s share price has seen a 7.31% 7 day gain to US$22.74, but its year to date share price return of 20.99% and 1 year total...